These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 16103866)

  • 41. [Pharmacologic therapy in peripheral diabetic polyneuropathy].
    Mihai B; Lăcătuşu C; Graur M; Cijevschi-Prelipcean C; Mihai C
    Rev Med Chir Soc Med Nat Iasi; 2010; 114(2):332-41. PubMed ID: 20700963
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Does the new antidepressant duloxetine (Cymbalta) have any advantages over other antidepressant drugs?
    Miller MC
    Harv Ment Health Lett; 2004 Nov; 21(5):8. PubMed ID: 15556908
    [No Abstract]   [Full Text] [Related]  

  • 43. Serotonin and noradrenaline involvement in urinary incontinence, depression and pain: scientific basis for overlapping clinical efficacy from a single drug, duloxetine.
    Thor KB; Kirby M; Viktrup L
    Int J Clin Pract; 2007 Aug; 61(8):1349-55. PubMed ID: 17608681
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Duloxetine: new indication. Depression and diabetic neuropathy: too many adverse effects.
    Prescrire Int; 2006 Oct; 15(85):168-72. PubMed ID: 17121211
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Possible drug-drug interaction between adalimumab and duloxetine and/or pregabalin in a psoriasis patient.
    Gupta R; Wu JJ; Levin E; Koo JY; Liao W
    J Drugs Dermatol; 2013 Oct; 12(10):1089. PubMed ID: 24085041
    [No Abstract]   [Full Text] [Related]  

  • 46. [Because depression also hurts: duloxetine can help patients return to vitality].
    MMW Fortschr Med; 2011 Apr; 153(14):76-7. PubMed ID: 21966877
    [No Abstract]   [Full Text] [Related]  

  • 47. Antinociceptive efficacy of lacosamide in a rat model for painful diabetic neuropathy.
    Beyreuther B; Callizot N; Stöhr T
    Eur J Pharmacol; 2006 Jun; 539(1-2):64-70. PubMed ID: 16682022
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The short- and long-term effect of duloxetine on painful physical symptoms in patients with generalized anxiety disorder: results from three clinical trials.
    Beesdo K; Hartford J; Russell J; Spann M; Ball S; Wittchen HU
    J Anxiety Disord; 2009 Dec; 23(8):1064-71. PubMed ID: 19643572
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Cymbalta in the treatment of chronic pain syndromes].
    Odinak MM; Kashin AV; Ememlin AIu
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(3):32-4. PubMed ID: 19365388
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prescribing patterns of duloxetine in France: a prescription assessment study in real-world conditions.
    Augendre-Ferrante B; Picard H; Evans D; Arkoub H; Pamulapati S; Perrot S; Valensi P; Rouillon F
    Int J Clin Pharmacol Ther; 2014 Jan; 52(1):1-7. PubMed ID: 24161159
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An update on the treatment and management of diabetic peripheral neuropathy.
    Donnan J; Ledger S
    CANNT J; 2006; 16(4):32-6; quiz 37-8. PubMed ID: 17252899
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Duloxetine contributing to a successful multimodal treatment program for peripheral femoral neuropathy and comorbid 'reactive depression' in an adolescent.
    Kachko L; Ben Ami S; Liberman A; Birk E; Kronenberg S
    Pain Res Manag; 2011; 16(6):457-9. PubMed ID: 22184557
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Psychiatry].
    Aubry JM; Delini-Stula A; Gervasoni N; Bryois C; Barbe R; Merlo M; Bertschy G
    Rev Med Suisse; 2007 Jan; 3(94):161-7. PubMed ID: 17354543
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Duloxetine related binge eating behaviors: a case report.
    Lai CH
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1581-2. PubMed ID: 19778574
    [No Abstract]   [Full Text] [Related]  

  • 55. Factors predicting reduced antidepressant response: experience with the SNRI duloxetine in patients with major depression.
    Howland RH; Wilson MG; Kornstein SG; Clayton AH; Trivedi MH; Wohlreich MM; Fava M
    Ann Clin Psychiatry; 2008; 20(4):209-18. PubMed ID: 19034753
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Dual mechanism of action. Remission of physical symptoms].
    MMW Fortschr Med; 2005 May; 147 Spec No 2():87. PubMed ID: 15968881
    [No Abstract]   [Full Text] [Related]  

  • 57. Duloxetine reduces chemotherapy induced peripheral neuropathy.
    BMJ; 2013 Apr; 346():f2199. PubMed ID: 23575568
    [No Abstract]   [Full Text] [Related]  

  • 58. Duloxetine use in chronic painful conditions--individual patient data responder analysis.
    Moore RA; Cai N; Skljarevski V; Tölle TR
    Eur J Pain; 2014 Jan; 18(1):67-75. PubMed ID: 23733529
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacotherapy of generalized anxiety disorder: results of duloxetine treatment from a pooled analysis of three clinical trials.
    Allgulander C; Hartford J; Russell J; Ball S; Erickson J; Raskin J; Rynn M
    Curr Med Res Opin; 2007 Jun; 23(6):1245-52. PubMed ID: 17559726
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Duloxetine for neuropathic pain based on recent clinical trials.
    Fishbain D; Berman K; Kajdasz DK
    Curr Pain Headache Rep; 2006 Jun; 10(3):199-204. PubMed ID: 18778574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.